Distalmotion has grabbed hold of a de novo clearance for its Dexter surgical robot, a system designed for hospitals as well as ambulatory surgery centers. The robotic assistant was cleared by the FDA ...

Distalmotion is pushing ahead in its U.S. market expansion with receipt of the Food and Drug Administration's go-ahead for a second set of indications in gynecology. The maker of the Dexter robotic ...

Distalmotion Supports ASCs in Expanding GYN Service Lines with US FDA 510(k) Clearance for Additional Gynecology Indications ...

Distalmotion’s Dexter Surgical Robot opens an entirely new era for soft tissue robotics in the outpatient setting and ambulatory surgery centers that will have immediate benefit for patients.

Lausanne, Switzerland, May 21, 2026 (GLOBE NEWSWIRE) -- CORRECTED: Distalmotion, the global MedTech company focused on empowering access to robotic surgery in outpatient settings, announced continued ...

Lausanne, Switzerland, May 28, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in more sites of care, today announced that it has ...

Editor’s note: This is the sixth article in a series of stories profiling medtech companies that are changing the field of robotic surgery. Read the other profiles here. More surgical procedures in ...

Lausanne, Switzerland, June 24, 2025 (GLOBE NEWSWIRE) -- Distalmotion, a global MedTech company advancing access to robotic surgery, has reached a key milestone in its US expansion with the first ...

Lausanne, Switzerland, June 16, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, today announced it has received 510(k ...